Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis.
Thell K, Hellinger R, Sahin E, Michenthaler P, Gold-Binder M, Haider T, Kuttke M, Liutkevičiūtė Z, Göransson U, Gründemann C, Schabbauer G, Gruber CW.
Thell K, et al. Among authors: hellinger r.
Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):3960-5. doi: 10.1073/pnas.1519960113. Epub 2016 Mar 28.
Proc Natl Acad Sci U S A. 2016.
PMID: 27035952
Free PMC article.